XML 36 R25.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Summary Components of Stock-Based Compensation Expense

The following table summarizes the components of stock-based compensation expense on the condensed consolidated statements of operations for the three months ended March 31, 2021 and 2020:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2021

 

 

2020

 

Cost of services

 

$

122

 

 

$

171

 

Cost of product sales

 

 

42

 

 

 

33

 

Selling, general and administrative

 

 

1,307

 

 

 

1,167

 

Product development

 

 

290

 

 

 

308

 

Total

 

$

1,761

 

 

$

1,679

 

Time-Based Stock Appreciation Rights [Member]  
Summary of Stock Appreciation Rights

A summary of the Company’s time-based stock appreciation rights (“SARs”) for the three months ended March 31, 2021 is as follows:

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

Intrinsic

 

 

 

Number of

 

 

Average

 

 

Contractual

 

 

Value

 

 

 

Shares

 

 

Exercise Price

 

 

Term (years)

 

 

(In thousands)

 

Outstanding at January 1, 2021

 

 

1,802,844

 

 

$

5.79

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(37,600

)

 

 

3.80

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(32,500

)

 

 

3.05

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2021

 

 

1,732,744

 

 

$

4.85

 

 

 

2.38

 

 

$

4,196

 

Exercisable at March 31, 2021

 

 

1,732,744

 

 

$

4.85

 

 

 

2.38

 

 

$

4,495

 

Vested and expected to vest at March 31, 2021

 

 

1,732,744

 

 

$

4.85

 

 

 

2.38

 

 

$

4,196

 

Performance-Based Stock Appreciation Rights [Member]  
Summary of Stock Appreciation Rights

A summary of the Company’s performance-based SARs for the three months ended March 31, 2021 is as follows:

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

Intrinsic

 

 

 

Number of

 

 

Average

 

 

Contractual

 

 

Value

 

 

 

Shares

 

 

Exercise Price

 

 

Term (years)

 

 

(In thousands)

 

Outstanding at January 1, 2021

 

 

78,921

 

 

$

3.16

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(17,450

)

 

 

3.36

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2021

 

 

61,471

 

 

$

3.61

 

 

 

1.73

 

 

$

827

 

Exercisable at March 31, 2021

 

 

61,471

 

 

$

3.61

 

 

 

1.73

 

 

$

827

 

Vested and expected to vest at March 31, 2021

 

 

61,471

 

 

$

3.61

 

 

 

1.73

 

 

$

827

 

Time-Based Restricted Stock Units [Member]  
Summary of Restricted Stock Units

A summary of the Company’s time-based restricted stock units (“RSUs”) for the three months ended March 31, 2021 is as follows:

 

 

 

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

 

Balance at January 1, 2021

 

 

1,297,273

 

 

$

4.90

 

Granted

 

 

97,302

 

 

 

7.06

 

Vested

 

 

(799,573

)

 

 

4.01

 

Forfeited or expired

 

 

(30,667

)

 

 

7.31

 

Balance at March 31, 2021

 

 

564,335

 

 

$

6.36

 

Performance-Based Restricted Stock Units [Member]  
Summary of Restricted Stock Units

A summary of the Company’s performance-based RSUs for the three months ended March 31, 2021 is as follows:

 

 

 

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

 

Balance at January 1, 2021

 

 

1,150,912

 

 

$

4.70

 

Granted

 

 

2,025

 

 

 

7.27

 

Vested

 

 

(326,863

)

 

 

3.92

 

Forfeited or expired

 

 

(370,340

)

 

 

3.95

 

Balance at March 31, 2021

 

 

455,734

 

 

$

6.17

 

Market Performance Units [Member]  
Fair Value of Stock Appreciation Rights Estimated

As the MPUs contain both performance and service conditions, they have been treated as a series of three separate awards, or tranches, for purposes of recognizing stock-based compensation expense. The Company recognizes stock-based compensation expense on a tranche-by-tranche basis over the requisite service period for each specific tranche. The Company estimated the fair values of the MPUs using a Monte Carlo simulation model that used the following assumptions:

 

 

 

Three Months Ended March 31,

 

 

2021

 

2020

Risk-free interest rate

 

0.06% to 0.30%

 

0.16% to 0.28%

Estimated volatility factor

 

60.0% to 81.0%

 

56.0% to 91.0%

Expected dividends

 

None

 

None